首页> 外文期刊>Blood and Lymphatic Cancer: Targets and Therapy >Uptake of lymphoma-derived exosomes by peripheral blood leukocytes
【24h】

Uptake of lymphoma-derived exosomes by peripheral blood leukocytes

机译:外周血白细胞摄取淋巴瘤来源的外来体

获取原文
           

摘要

Exosomes are nanosized lipid vesicles secreted into blood and other body fluids and serve as vehicles for intercellular communication. Despite being an important component of the tumor microenvironment (TME), exosomal targeting and uptake into recipient cells are still not fully understood. Few studies have looked at lymphoma exosomes and their interactions with circulating blood cells. In this study, we examine the exosomal uptake distribution among peripheral blood leukocytes (PBLs) using vesicles derived from a diffuse large B cell lymphoma cell line, WSU-DLCL2. Lymphoma cells survive, proliferate, and are protected from the cytotoxic effects of chemotherapeutic agents by soluble factors or by direct contact with inflammatory and stromal cells within the TME. In an attempt to close the gap in knowledge concerning lymphoma TME immunosuppression, we have treated normal human PBLs with PKH67-labeled lymphoma exosomes and monitored the uptake by measuring fluorescence at different time points using flow cytometry and fluorescent microscopy. Our results show that of the four populations examined, B cells and monocytes demonstrated uptake of PKH67-labeled exosomes, while T cells and NK cells displayed significantly less uptake.
机译:外泌体是分泌到血液和其他体液中的纳米级脂质囊泡,可作为细胞间通讯的载体。尽管是肿瘤微环境(TME)的重要组成部分,外泌体靶向和摄取到受体细胞中仍然没有完全了解。很少有研究关注淋巴瘤外泌体及其与循环血细胞的相互作用。在这项研究中,我们检查了使用来自弥漫性大B细胞淋巴瘤细胞系WSU-DLCL2的囊泡在外周血白细胞(PBL)中的外泌体吸收分布。淋巴瘤细胞可以通过可溶性因子或与TME中的炎症细胞和基质细胞直接接触来生存,增殖并免受化学治疗剂的细胞毒作用。为了缩小关于淋巴瘤TME免疫抑制的知识差距,我们用PKH67标记的淋巴瘤外泌体治疗了正常人PBL,并通过使用流式细胞仪和荧光显微镜在不同时间点测量荧光来监测摄取。我们的结果表明,在所检查的四个种群中,B细胞和单核细胞表现出摄取PKH67标记的外来体,而T细胞和NK细胞表现出明显更少的摄取。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号